In 2023, nervous system medicine sales in Germany stood at an approximate value of 84 US Dollars per capita. The projected data from 2024 to 2028 indicate a steady annual increase: 1.3% for 2024-2025, 1.3% for 2025-2026, 1.3% for 2026-2027, and 1.2% for 2027-2028. The 5-year compound annual growth rate (CAGR) from 2024 to 2028 is estimated at 1.3%, reflecting consistent growth.

Future trends to watch for include:

The impact of emerging innovative therapies and technologies in nervous system medicine.
Healthcare policy changes affecting drug pricing and accessibility in Germany.
Demographic shifts, particularly the aging population, driving increased demand.
Potential economic fluctuations influencing healthcare spending priorities.